Kanaph Therapeutics Inc. – Trademark Portfolio

Entity Type: 03

Kanaph Therapeutics Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include TMEKINE and KANAPH THERAPEUTICS INC.. The owner is based in Yongsan-gu, Seoul.

5F, 3, Itaewon-ro 55ga-gil

Yongsan-gu, Seoul 04348 , KR

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Kanaph Therapeutics Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

44
Medical Services (4 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Kanaph Therapeutics Inc. have?

Kanaph Therapeutics Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending.

What trademark classes does Kanaph Therapeutics Inc. file in?

Kanaph Therapeutics Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Kanaph Therapeutics Inc.'s most well-known trademarks?

Kanaph Therapeutics Inc.'s registered trademark portfolio includes well-known marks such as TMEKINE and KANAPH THERAPEUTICS INC.. These are among 3 currently registered trademarks in the portfolio.

What is Kanaph Therapeutics Inc.'s trademark registration success rate?

Kanaph Therapeutics Inc. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.